Infectious Diseases

With concerns of bioterrorism in mind, the US Food and Drug Administration has approved the first drug with an indication for the treatment of smallpox.

The FDA has issued label changes for a class of antibiotics used for the treatment of certain serious bacterial infections.

The US Food and Drug Administration advisory committee has released its recommendations regarding the components of the 2018-2019 influenza vaccine.

The FDA has expanded the indication for a drug formerly approved for the treatment of patients with complicated intra-abdominal infections and complicated urinary tract infections.

The US Food and Drug Administration has approved a new option for the treatment of bacterial vaginosis in adult women.

The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.

After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.

The FDA has issued a revision to their February 2016 guidance for the screening of whole blood and blood components for Zika virus.

The FDA has approved a new option for the treatment and prevention of pneumonic and septicemic plague.

Primary care practitioners should be aware of new FDA approvals for treating hepatitis C, peripheral artery disease, and chemotherapy-related nausea.